186899 – Clinical Research Fellow in Translational Myeloma Research
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS)
Grade E63: £38,831 - £52,656 per annum dependent on qualifications and experience, in line with current pay protection and transitional arrangements in the NHS.
This is a part time (40% FTE), fixed term position 12 months.
The University of Oxford is a stimulating work environment, which enjoys an international reputation as a world-class centre of excellence. Our research plays a key role in tackling many global challenges, from reducing our carbon emissions to developing vaccines during a pandemic.
The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is part of the Medical Sciences Division and is the largest European academic department in its field, running a globally competitive programme of research and teaching.
The Botnar Institute for Musculoskeletal Sciences enables and encourages research and education into the causes of musculoskeletal disease and their treatment. The Centre provides world-class facilities for scientists in the field of musculoskeletal research.
The postholder will play a key role in supporting OTMC’s portfolio of translational and pre-clinical research studies, including next-generation single cell and spatial transcriptomic, epigenomic and proteomic data generation, biomarker sample collection, and computational analysis, with a particular focus on the bone marrow microenvironment and stromal cell biology in myeloma.
What We Offer
As an employer, we genuinely care about our employees’ wellbeing and this is reflected in the range of benefits that we offer including:
- An excellent contributory pension scheme
- A comprehensive range of childcare services
- Discounted bus travel and Season Ticket travel loans
- Membership to a variety of social and sports clubs
About the Role
The Oxford Translational Myeloma Centre (OTMC) is seeking to appoint a motivated and enthusiastic Clinical Research Fellow to join its dynamic and expanding programme of translational research in myeloma in the group of Professor Oppermann. This is an exciting opportunity to contribute to cutting-edge research aimed at improving outcomes for patients with myeloma and related plasma cell disorders. In this role you will contribute actively to the conduct, and delivery of high-quality translational myeloma research in collaboration with clinical, academic, and industry partners. You will participate in and contribute to multidisciplinary team meetings, trial clinics, and service development, particularly in the delivery of advanced therapies. You will be responsible for identifying and undertaking a translational research project under the supervision of a senior academic mentor as well as conduct experimental studies such as single-cell and spatial data generation using a suite of experimental approaches including transcriptomic, genomic and proteomic assays.
About You
You will hold an undergraduate degree with honours in medicine and have a full registration (and a licence to practise) with the General Medical Council (GMC) with evidence of some sub-specialty training in Haematology. You will also hold a PhD with focus on inflammatory, degenerative or malignant disorders. You will currently hold a core clinical training post or equivalent and have experience of clinical haematology and working on related clinical audits. You will have experience in primary cell culture and functional assays, including handling of patient-derived material together with experience in next generation sequencing platforms (e.g. single cell sequencing, spatial transcriptomics) and proficiency in bioinformatic analysis. Experience of cross-institutional collaboration with leading academic and industry groups as well as a track record of competitive externally-funded research fellowships and international conference presentations are desirable.
Application Process
You will be required to upload a covering letter/supporting statement, CV and the details of two referees as part of your online application. Please quote 186899 in all correspondence.
The closing date for applications is 12pm 29 June 2026.
Interviews will take place during week commencing 6 July 2026 and will be hybrid**.**
